[Nutritional risk to pediatric internation (pilot study).]

Gerardo Weisstaub1, Laura Arce, Victoria Brennan

  • 1INTA, Universidad de Chile. gweiss@inta.uchile.cl.

Insights

Pediatric malnutrition at hospital admission affects nearly 20% of children, with over half at moderate nutritional risk. This highlights the critical need for routine nutritional status assessments in hospitalized pediatric patients.

Area of Science:

  • Pediatric Medicine
  • Clinical Nutrition
  • Public Health

Background:

  • Malnutrition in hospitalized children is a significant risk factor for adverse outcomes, including increased morbidity and mortality.
  • Early identification of nutritional status is crucial for improving patient care and prognosis.

Purpose of the Study:

  • To determine the prevalence of malnutrition and undernourishment upon hospital admission in pediatric patients.
  • To assess the frequency of nutritional risk among hospitalized children.

Main Methods:

  • A descriptive cross-sectional study was conducted at Hospital Dr. Humberto Notti.
  • Nutritional screening using the Strong Kids tool was performed within 48 hours of admission.
  • Anthropometric data were collected for nutritional diagnosis, with statistical analysis using Fisher and Student tests.

Main Results:

  • Out of 134 pediatric patients, 17% presented with acute malnutrition at admission.
  • A substantial 60% of patients were identified as having moderate nutritional risk.
  • Patients with high nutritional risk experienced more frequent symptoms like pain, weight changes, reduced appetite, and diarrhea.

Conclusions:

  • Approximately 20% of pediatric patients are malnourished or undernourished upon admission.
  • More than half of hospitalized children exhibit moderate nutritional risk.
  • Systematic nutritional status evaluation is essential for all pediatric hospital admissions.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
196
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
108
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
646
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
580
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
154
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
210